Arrow Pharmaceuticals Competitors and Similar CompaniesClear all

Arrow Pharmaceuticals's competitors and similar companies include Ionis Pharmaceuticals, Intellia Therapeutics, Rocket Pharmaceuticals and RD-Biotech.

	Arrow Pharmaceuticals Arrow Pharmaceuticals is a company that specializes in provides pharmaceutical and genetic products.	Ionis Pharmaceuticals Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.	Intellia Therapeutics Intellia Therapeutics is a genome editing company that caters to the biotechnology industry.	Rocket Pharmaceuticals Rocket Pharmaceuticals is a biotechnology company focused on seeking cures through molecular and gene therapy.	RD-Biotech RD-Biotech is a biotechnology company that offers customized solutions in genomics, immunology, and cell engineering.
Founding Date	Founding Date 2015	Founding Date 1989	Founding Date 2014	Founding Date 2018	Founding Date 2002
Type	Type Private	Type Public	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech clinical research healthtech	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma
Locations	Locations Cremorne, AU HQ	Locations Carlsbad, US HQ Vancouver, CA Stuttgart, DE Dublin, IE Dublin, IE Lisboa, PT London, GB see more	Locations Cambridge, US HQ	Locations East Windsor, US HQ New York, US	Locations Besançon, FR HQ Saint Genis Laval, FR
Employees	Employees 512% increase	Employees 1,40231% increase	Employees 40323% decrease	Employees 5716% increase	Employees 613% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 6.3 b	Valuation ($) 1.7 b	Valuation ($) 1.6 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $943.7m (FY, 2025)	Revenue (est.) $67.7m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $15.9m (FY, 2025)	Cost of goods N/A	Cost of goods $1.1m (FY, 2025)	Cost of goods N/A
Net income	Net income N/A	Net income ($381.4m) (FY, 2025)	Net income ($412.7m) (FY, 2025)	Net income ($223.1m) (FY, 2025)	Net income N/A